Table 1.
Association between NLR/PNI value and clinicopathological findings
| Number | NLR | PNI | |
|---|---|---|---|
| All cases | 334 | 2.52 ± 2.06 | 51.03 ± 5.72 |
| Age | |||
| ≦70 | 165 | 2.34 ± 1.91 | 52.20 ± 5.38* |
| >70 | 169 | 2.69 ± 2.18 | 49.59 ± 5.70* |
| Smoking history | |||
| Never | 122 | 2.27 ± 1.69 | 52.32 ± 5.00**, *** |
| Former | 116 | 2.69 ± 2.41 | 49.70 ± 5.65** |
| Current | 95 | 2.64 ± 1.99 | 50.97 ± 6.36*** |
| Histology | |||
| Adenocarcinoma | 231 | 2.43 + 2.07 | 51.87 + 5.17**** |
| Squamous cell carcinoma | 69 | 2.80 + 2.30 | 48.22 + 6.49**** |
| Large cell carcinoma | 22 | 2.84 + 1.42 | 49.55 + 6.38 |
| Adenosquamous carcinoma | 6 | 2.01 + 0.61 | 52.49 + 2.39 |
| Pleomorphic carcinoma | 6 | 1.90 + 0.93 | 55.07 + 6.92 |
| Tumor differentiation | |||
| Well | 118 | 2.39 + 2.12 | 51.82 + 4.70 |
| Moderate | 115 | 2.55 + 2.29 | 50.96 + 6.12 |
| Poor | 101 | 2.59 + 1.70 | 50.23 + 6.30 |
| Pathological stage | |||
| IA | 144 | 2.40 + 2.13 | 51.74 + 5.33 |
| IB | 95 | 2.54 + 1.68 | 50.30 + 6.00 |
| IIA+IIB | 55 | 2.60 + 2.21 | 50.30 + 5.50 |
| IIIA+IIIB | 40 | 2.75 + 2.37 | 51.18 + 6.58 |
NLR neutrophil/lymphocyte ratio, PNI prognostic nutritional index
*, **, ****p < 0.01
***p < 0.05